| T O P I C R E V I E W |
| jabsadmin |
Posted - 09/03/2006 : 10:04:42
SUNDAY EXPRESS
3 September 2006
Report links 'super dose' to thousands of adverse reactions in US children
Fears new 7-in-1 meningitis jab endangers lives
By Lucy Johnston
Health Editor
Babies given a "super dose" vaccine due to be launched tomorrow risk serious side effects and even death, a report claims.
Prevenar, will be added to the childhood immunisation programme containing vaccines against seven strains of meningitis.
The drug is designed to combat bacteria that cause diseases such as pneumonia and blood poisoning as well as meningitis. It provokes the body's immune response to the bacteria without causing the diseases.
But a report, The Next Storm, reveals that the jab, combined with other childhood inoculations, has been linked to breathing problems, brain damage, convulsions, extreme allergic shock and death.
A similar combination of vaccines has been given to babies in the US for more than five years.
The report's author, Dr Edward Yazbak, is an American child vaccination specialist who has analysed reports of side-effects received by the American Vaccine Adverse Events Reporting System.
He discovered thousands of reactions linked with Prevenar.
Since March 2000 there has been 11,611 adverse reports following the jab including 362 deaths and 1,347 hospitalisations, although Dr Yazbak pointed out that a report does not prove the jab caused the reaction.
He said: "Such a combination of jabs has been linked with serious reactions and death in this country. The authorities in Britain should be very alert to what happens when all these
vaccines are given together."
His study has led to calls for an overhaul of the UK vaccination programme, which will see babies receiving 25 inoculations by the time, they are 13 months old.
Doctors and health expert say there have been no long-term studies into the dangers.
Liberal Democrat health spokeswoman Sandra Gidley said: "We shouldn't be doing this until we know more about what happens long term."
Dr Peter Mansfield, who won a case against the doctor's governing body, the General Medical Council, for refusing to give the measles, mumps and rubella jab to infants, said: "We're vaccinating babies when their immune systems are not ready. We're breaking the rules of nature and we really don't know what the result will be."
Jackie Fletcher from Jabs, a support group for parents who believe their children have been damaged by vaccines, wrote to the Chief Medical Officer, Professor Liam Donaldson, asking for evidence that the new schedule has been properly tested. She has received no reply.
She said: "Doctors have raised serious concerns about the old schedule. Surely we need to ensure this is safe before introducing new ones?"
"Single jabs have been phased out without any consultation. Families should be given a range of options."
In a statement to the Sunday Express, Sir Liam said the new jab had been introduced, "on the best available scientific and medical evidence."
He added: "This will save many babies' lives a year as well as preventing hundreds more cases of serious illness and disability."
The new schedule
At 2 months babies will be given the five-in-one - diphtheria, tetanus, whooping cough, hib meningitis and polio - and Prevenar.
At 3 months they will get a repeat of the five-in-one and a dose of Meningitis C.
At 4 months they will receive a third shot of the five-in-one with Prevenar and meningitis C.
At 12 months hib meningitis and meningitis C.
At 13 months they will get the MMR together with Prevenar, making a total of 25 jabs.
----------------------------------
Note from JABS: Here's a direct link to Dr Yazbak's report:
The U.K. Pediatric Pneumococcal Vaccine
The Next Storm
http://www.jabs.org.uk/pages/nextStorm.doc
|
| 6 L A T E S T R E P L I E S (Newest First) |
| jabsadmin |
Posted - 04/21/2008 : 12:52:40
http://www.dcthomson.co.uk/mags/post/postindex.htm
SUNDAY POST
20 April 2008
Fears as child chest infections rocket
By Iain Harrison
THE number of Scots children rushed to hospital with pneumonia has rocketed by more than 50 per cent in three years.
This coincides with the introduction of a new vaccination against the condition in 2006.
While a child health expert insists there’s no connection between the two, the Scottish Government has ordered an urgent investigation after we presented the findings to them.
Newly released NHS Scotland data shows 2454 children were hospitalised for pneumonia in 2006/07 — compared with 1620 in 2003/04.
Under-fours
The problem is especially pronounced in infants, with 65 per cent of emergency hospital admissions for the condition involving under-fours.
Statistics also reveal the number of under-15s dying from all respiratory illnesses has climbed from seven in 2004 to 12 in 2006 — a rise of 71 per cent.
Last night, Dr Richard Simpson, Labour’s shadow minister for public health, described the figures as “worrying”.
He said, “In 2006 a vaccine against the pneumococcal infection was introduced into the childhood immunisation schedule and the uptake has been very high.
“This will go some way to reducing the numbers of children from future generations who are admitted to hospital with pneumonia.
“But it may be necessary to consider a catch-up programme for older children, an appropriate course of action if there were serious concerns about an epidemic.”
No link
Dr David Spencer, a consultant respiratory paediatrician in Newcastle, insists the rise in hospital admissions is not linked to the UK-wide introduction of the pneumococcal vaccine.
But he said it might be down to an increase in the number of children being struck down with more complicated strains of the illness.
“The pneumococcal vaccine has had a dramatic beneficial effect in reducing hospital admissions,” he added.
“The vaccine protects against seven common pneumonia strains and has been very successful in reducing cases among children.
“It was introduced into the US around seven years ago and was responsible for about a 40 per cent decrease in admissions for pneumonia in infants and young children, so it’s a very good thing.
“But the vaccine doesn’t presently cover serotype one, which infects the lining of the lungs and can cause a great deal of pain.
“Years ago, serotype one was not common in the UK, but over the last 15 years we’ve seen an increase in the number of cases of the strain.
“Last year we saw 70 cases of serotype one at our Newcastle centre alone. This rise may explain the increase in hospital admissions in Scotland.”
Concern
Despite this, Dr Spencer admitted the introduction of the vaccine could potentially lead to increases in cases involving serotype one.
“The pneumonia bug lives in peace with us for most of the time, but it does not like a vacuum,” he explained.
“If you take away one of the types of serotype by vaccination then another may then take its place.
“I contacted the Health Protection Agency 18 months ago and expressed concern there was a potential for the vaccine to make things worse.
“A new version of this vaccine, which will probably be introduced in about two years, will address this.”
A recent study by Emeritus Professor George Knox, of Birmingham University, found an “exceptional” link between an increase in pneumonia deaths in England and car exhaust fumes.
He said, “The number of children being hospitalised with pneumonia in Scotland is very concerning.”
Investigating
A Scottish Government spokeswoman said they’d be probing the rises.
“There may be a number of reasons for these increases and we’ll be investigating this,” she added.
“A range of initiatives are under way to reduce respiratory conditions, including pneumococcal vaccinations as part of the childhood vaccination programme and also for the elderly, and a seasonal flu vaccination programme every year.
“Further research is needed to establish whether the concentrations of pollutants of the order present in Professor Knox’s findings can be linked to increases in deaths from pneumonia.”
Pneumonia, or inflammation of the lungs, is usually caused by an infection and symptoms include chest pain, high fever and breathlessness.
Antibiotics can often control it, but complications can be life-threatening.
|
| jacquia |
Posted - 09/24/2006 : 15:28:13
Taken from this websitehttp://www.drjaygordon.com/development/pediatricks/vacctoday.asp
The Prevnar vaccine was invented to protect higher-risk individuals from a particular group of dangerous bacteria. It was never intended to be, and is not very effect as, an "ear infection" shot. The diseases that it prevents are extremely rare
So why does our government wantto give it to all our young children??? I have to conceed that there are big bucks involved. |
| jacquia |
Posted - 09/24/2006 : 15:09:42
Oh my, I look and I find more and more information suggesting that prevnar is not that safe.
http://www.nccn.net/~wwithin/prevnar.htm |
| jacquia |
Posted - 09/24/2006 : 15:05:01
Small section from a report on
http://www.whale.to/vaccines/prevnar333.html
Wyeth's own internal investigations were also found to be inadequate.
"Manufacturing investigation reports are not always completed in a timely
manner," the FDA inspectors wrote in reviewing Wyeth's compliance in
correcting previously cited problems. "Further," they said, "there is a lack
of evidence that product impact is addressed in a timely manner and that all
batches/processes are fully investigated."
In one FDA report alone, inspectors identified 59 problems.
In 2001 and 2002, Livingston says he repeatedly reported the violations to
the managing director at the plant, an outside auditor, and a quality
council of managers and nothing was done to correct the problems.
Livington says he was also concerned about the dangerous working conditions
for employees. "I had many manufacturing technicians from 2000-2002 tell
me," he said, "they did not want to work in the Prevnar manufacturing area
for fear of the chemicals used in the production process, including
cyanide."
"Sodium cyanide is a dangerous chemical," he says, "mix it with water and
you get hydrogen cyanide, the gas of choice used in the Holocaust."
Sodium cyanide is used in the Prevnar manufacturing process, but trace
amounts remain in the vaccine itself, according to Livingston.
There are in fact, he says, many toxic substances in vaccines. "Mercury,
lead, aluminum, cyanide, it's not a pretty picture," Livingston warns, "for
a child's immune system, for unsuspecting parents and caregivers, who are
never told about the presence of these chemicals, and for employees who have
to keep their mouths shut or face losing employment," he adds.
SCARY STUFF!!! |
| jacquia |
Posted - 09/24/2006 : 14:51:24
Fever, and rarely febrile seizure, have been reported in children receiving Prevnar®. For children at higher risk of seizures than the general population, acetaminophen or other appropriate antipyretics (dosed according to respective prescribing information) may be administered around the time of vaccination, to reduce the possibility of post-vaccination fever.
General
CARE IS TO BE TAKEN BY THE HEALTHCARE PROFESSIONAL FOR THE SAFE AND EFFECTIVE USE OF THIS PRODUCT.
1. PRIOR TO ADMINISTRATION OF ANY DOSE OF THIS VACCINE, THE PARENT OR GUARDIAN SHOULD BE ASKED ABOUT THE PERSONAL HISTORY, FAMILY HISTORY, AND RECENT HEALTH STATUS OF THE VACCINE RECIPIENT. THE HEALTHCARE PROFESSIONAL SHOULD ASCERTAIN PREVIOUS IMMUNIZATION HISTORY, CURRENT HEALTH STATUS, AND OCCURRENCE OF ANY SYMPTOMS AND/OR SIGNS OF AN ADVERSE EVENT AFTER PREVIOUS IMMUNIZATIONS IN THE CHILD TO BE IMMUNIZED, IN ORDER TO DETERMINE THE EXISTENCE OF ANY CONTRAINDICATION TO IMMUNIZATION WITH THIS VACCINE AND TO ALLOW AN ASSESSMENT OF RISKS AND BENEFITS.
2. BEFORE THE ADMINISTRATION OF ANY BIOLOGICAL, THE HEALTHCARE PROFESSIONAL SHOULD TAKE ALL PRECAUTIONS KNOWN FOR THE PREVENTION OF ALLERGIC OR ANY OTHER ADVERSE REACTIONS. This should include a review of the patient’s history regarding possible sensitivity; the ready availability of epinephrine 1:1000 and other appropriate agents used for control of immediate allergic reactions; and a knowledge of the recent literature pertaining to use of the biological concerned, including the nature of side effects and adverse reactions that may follow its use.
3. Children with impaired immune responsiveness, whether due to the use of immunosuppressive therapy (including irradiation, corticosteroids, antimetabolites, alkylating agents, and cytotoxic agents), a genetic defect, HIV infection, or other causes, may have reduced antibody response to active immunization.36,37,38 (See DRUG INTERACTIONS.)
4. The use of pneumococcal conjugate vaccine does not replace the use of 23-valent pneumococcal polysaccharide vaccine in children #61619;#61472;24 months of age with sickle cell disease, asplenia, HIV infection, chronic illness or who are immunocompromised. Data on sequential vaccination with Prevnar®followed by 23-valent pneumococcal polysaccharide vaccine are limited. In a randomized study, 23 children ³ 2 years of age with sickle cell disease were administered either 2 doses of Prevnar®followed by a dose of polysaccharide vaccine or a single dose of polysaccharide vaccine alone. In this small study, safety and immune responses with the combined schedule were similar to polysaccharide vaccine alone.39
5. Since this product is a suspension containing an aluminum adjuvant, shake vigorously immediately prior to use to obtain a uniform suspension prior to withdrawing the dose.
6. A separate sterile syringe and needle or a sterile disposable unit should be used for each individual to prevent transmission of hepatitis or other infectious agents from one person to another. Needles should be disposed of properly and should not be recapped.
7. The vaccine is to be administered immediately after being drawn up into a syringe.
8. Special care should be taken to prevent injection into or near a blood vessel or nerve.
9. Healthcare professionals should prescribe and/or administer this product with caution to patients with a possible history of latex sensitivity since the packaging contains dry natural rubber.
INFORMATION FOR PARENTS OR GUARDIANS
Prior to administration of this vaccine, the healthcare professional should inform the parent, guardian, or other responsible adult of the potential benefits and risks to the patient (see ADVERSE REACTIONS and WARNINGS sections), and the importance of completing the immunization series unless contraindicated. Parents or guardians should be instructed to report any suspected adverse reactions to their healthcare professional. The healthcare professional should provide vaccine information statements prior to each vaccination.
CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY
Prevnar®has not been evaluated for any carcinogenic or mutagenic potential, or impairment of fertility.
PREGNANCY
Pregnancy Category C
Animal reproductive studies have not been conducted with this product. It is not known whether Prevnar®can cause fetal harm when administered to a pregnant woman or whether it can affect reproductive capacity. This vaccine is not recommended for use in pregnant women.
Nursing Mothers
It is not known whether vaccine antigens or antibodies are excreted in human milk. This vaccine is not recommended for use in a nursing mother.
PEDIATRIC USE
Prevnar®has been shown to be usually well-tolerated and immunogenic in infants. The safety and effectiveness of Prevnar®in children below the age of 6 weeks or on or after the 10th birthday have not been established. Immune responses elicited by Prevnar®among infants born prematurely have not been studied. See DOSAGE AND ADMINISTRATION for the recommended pediatric dosage.
GERIATRIC USE
This vaccine is NOT recommended for use in adult populations. It is not to be used as a substitute for the pneumococcal polysaccharide vaccine in geriatric populations.
|
| jabsadmin |
Posted - 09/24/2006 : 14:15:33
SUNDAY EXPRESS 24th September 2006
Super-jabs babies end up in casualty.
By Lucy Johnston
HEALTH EDITOR
Babies given the new superdose vaccine combination are more likely to end up in casualty, an alarming new report shows.
A study compared babies given the new vaccine schedule - which combines 12 vaccines in two shots - with babies given seperate injections.
It showed those who had the combined shot were twice as likely to visit casualty units as those given the older seperate version.
One in 100 of these suffered fevers. The super-dose babies were seven times more likely to be given invasive tests within three days of the innoculation - including taking samples of blood, urine and spinal fluid.
The infants, all between six and 10 weeks old were also three times more likely to be given antibiotics within seven days of the vaccine if they had received the combination jabs. Dr. Lindsay Thompson, lead author of the US report said: "Reducing the number of shots is wonderful, but when you combine it with the two other shots, also routinely given, there is an increased risk of fever."
Jackie Fletcher, of British support group Jabs said: "This study shoots down the myth that the Department of Health keeps perpetuating - that babies can take thousands of vaccines without harm."
The research, which bears out a report by the Sunday Express earlier this month, analyse babies given the American version of the UK jab. It was published in the Paedriatric Infectious Disease Journal. |
|
|
